Ozempic, Rybelsus and Wegovy top the list of the newest drugs selected for Medicare Part price negotiation, part of the ...

But many existing models fall short of adhering to established best practices for economic evaluation, the review authors ...

Mayo Clinic researchers find that stem cells with the highest Myc expression become dominant in driving lung remodeling .

Michael Poku, M.D., chief clinical officer of Equality Health, shared his prediction for 2025.

Five-year survival rates improved greatly because of immunotherapy and other advances, according to the American Cancer ...

As 2025 approaches, the healthcare landscape is undergoing rapid transformation. Rising healthcare utilization, escalating ...

A prediction for 2025 from Laura Kohlhagen, M.D., MBA, chief medical officer, of Altera Digital Health.

This ranking is based on the reviews of 12,372 consumers who evaluated their experiences with 16 major health insurance ...

More than half (53%) of patients reached remission after one year of Omvoh treatment and 46% experienced healing of the ...

In an investor call, Andrew Witty promised full transparency and 100% pass-through rebates for prescription drugs by 2028.

In 2024, UnitedHealth Group saw full year revenue grow 8% over 2023 to reach $400.3 billion. Adjusted earnings from ...